TMCI Treace Medical Concepts, Inc. - Common Stock
$2,75
Prix · Mai 20, 2026
Données fondamentales au Mai 8, 2026
Fourchette 52 semaines
$1–$8
24% of range
Note des analystes
HOLD
10 analysts
Objectif de cours
$4
+45% upside
P/E (TTM)
-2.6
ROE
-63.8%
Marge nette
-27.7%
TMCI Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$2.75
Capitalisation Boursière
—
P/E (TTM)
-2.6
BPA (TTM)
$-0.93
Revenus (TTM)
$213M
Rendement div.
—
ROE
-63.8%
Dette/Capitaux propres
0.7
Fourchette 52 semaines
$1 – $8
TMCI Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$213M
2019-12-31
→
2025-12-31
BPA
$-0.93
2020-12-31
→
2025-12-31
Flux de trésorerie libre
$-29M
2021-12-31
→
2025-12-31
Marges
-27.7%
2021-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
TMCI
Médiane des pairs
P/E (TTM)
-2.6
42.7
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
TMCI
Médiane des pairs
Gross Margin (Marge Brute)
79.8%
70.8%
Operating Margin (Marge d'exploitation)
-25.5%
—
Net Profit Margin (Marge nette)
-27.7%
-34.0%
ROA
-28.9%
-23.6%
ROE
-63.8%
-25.2%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
TMCI
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.7
102.9
Current Ratio (Ratio de liquidité)
4.3
4.4
Quick Ratio (Ratio de liquidité réduite)
3.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
TMCI
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
1.6%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
14.5%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
30.0%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
TMCI
Médiane des pairs
TMCI Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
CONSERVER
10 analystes
- Achat fort 0 0,0%
- Achat 1 10,0%
- Conserver 5 50,0%
- Vente 2 20,0%
- Vente forte 2 20,0%
Objectif de cours à 12 mois
3 analystes · 2026-05-18
Médiane
$3.00
Moyenne
$4.00
Maintenant
$2.75
Bas
$2.00
Haut
$7.00
Objectif médian
$3.00
+9,1%
Objectif moyen
$4.00
+45,5%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.03%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.28 | $-0.31 | 0.03% |
| 31 décembre 2025 | $-0.15 | $-0.15 | 0.00% |
| 30 septembre 2025 | $-0.26 | $-0.29 | 0.03% |
| 30 juin 2025 | $-0.28 | $-0.29 | 0.01% |
| 31 mars 2025 | $-0.25 | $-0.31 | 0.06% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| TMCI | — | -2.6 | 1.6% | -27.7% | -63.8% | 79.8% |
| LUCD | $143M | -1.1 | 8.3% | -1232.7% | -617.2% | — |
| PDEX | $142M | 16.3 | 23.7% | 13.5% | 26.2% | 29.3% |
| KRMD | $269M | -96.8 | 22.2% | -6.4% | -15.7% | 62.3% |
| KRMD | $269M | -96.8 | 22.2% | -6.4% | -15.7% | 62.3% |
| INGN | $183M | -7.8 | 3.9% | -6.5% | -11.6% | 44.2% |
| OWLT | — | -5.5 | 35.4% | — | — | — |
| CVRX | $187M | -3.5 | 10.4% | -94.1% | -109.6% | 85.3% |
| APYX | $146M | -6.1 | 9.9% | -21.2% | -78.0% | 62.5% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $213M | $209M | $187M | $142M | $94M | $57M | |
| Cost of Revenue | $43M | $41M | $35M | $26M | $17M | $12M | |
| Gross Profit | $170M | $168M | $152M | $116M | $78M | $45M | |
| R&D Expense | $20M | $21M | $15M | $14M | $10M | $6M | |
| SG&A Expense | $63M | $56M | $47M | $33M | $18M | $7M | |
| Operating Expenses | $224M | $224M | $203M | $151M | $94M | $44M | |
| Operating Income | $-54M | $-56M | $-51M | $-35M | $-17M | $855.0K | |
| Interest Expense | $5M | $5M | $5M | $4M | $4M | $3M | |
| Other Non-op | $-5M | $-55.0K | $2M | $-8M | $-4M | $-5M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-59M | $-56M | $-50M | $-43M | $-21M | $-4M | |
| EPS (Basic) | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.43 | $-0.12 | |
| EPS (Diluted) | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.43 | $-0.12 | |
| Shares (Basic) | 63,269,003 | 62,112,037 | 60,852,153 | 55,276,834 | 48,415,679 | 37,068,965 | |
| Shares (Diluted) | 63,269,003 | 62,112,037 | 60,852,153 | 55,276,834 | 48,415,679 | 37,068,965 | |
| EBITDA | $-44M | · | $-46M | $-33M | $-16M | · |
Bilan 30
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $11M | $13M | $19M | $106M | $18M | |
| Short-term Investments | $38M | $64M | $110M | $62M | $0 | · | |
| Receivables | $42M | $41M | $38M | $29M | $19M | $14M | |
| Inventory | $36M | $39M | $29M | $19M | $11M | $8M | |
| Prepaid Expense | $6M | $6M | $8M | $4M | $3M | $593.0K | |
| Current Assets | $132M | $161M | $198M | $133M | $138M | $41M | |
| PP&E (Net) | $30M | $26M | $22M | $15M | $3M | $829.0K | |
| PP&E (Gross) | $54M | $41M | $31M | $20M | $6M | $3M | |
| Accum. Depreciation | $24M | $15M | $9M | $4M | $3M | $3M | |
| Goodwill | $13M | $13M | $13M | $0 | · | · | |
| Intangibles | $7M | $8M | $9M | $0 | · | · | |
| Other Non-current Assets | $1M | $407.0K | $146.0K | $146.0K | $0 | · | |
| Total Assets | $191M | $217M | $252M | $159M | $141M | $42M | |
| Accounts Payable | $7M | $11M | $12M | $9M | $4M | $2M | |
| Accrued Liabilities | $6M | $7M | $10M | $6M | $5M | $2M | |
| Short-term Debt | $2M | $0 | · | · | · | · | |
| Current Liabilities | $31M | $35M | $45M | $30M | $18M | $12M | |
| Capital Leases | $14M | $16M | $16M | $16M | $0 | · | |
| Other Non-current Liabilities | $3M | $37.0K | $37.0K | $0 | · | · | |
| Total Liabilities | $103M | $104M | $114M | $98M | $48M | $41M | |
| Long-term Debt | $56M | $53M | $53M | $53M | $29M | $31M | |
| Total Debt | $57M | · | $53M | $53M | $29M | · | |
| Common Stock | $64.0K | $62.0K | $62.0K | $55.0K | $45.0K | $28.0K | |
| Paid-in Capital | $337M | $303M | $272M | $145M | $135M | $14M | |
| Retained Earnings | $-249M | $-190M | $-134M | $-85M | $-42M | $-21M | |
| Treasury Stock | $1M | $281.0K | $13.0K | $0 | · | · | |
| AOCI | $72.0K | $97.0K | $163.0K | $-27.0K | $0 | · | |
| Stockholders' Equity | $87M | $113M | $138M | $61M | $93M | $776.0K | |
| Liabilities + Equity | $191M | $217M | $252M | $159M | $141M | $42M | |
| Shares Outstanding | · | · | 61,749,654 | 55,628,208 | 54,181,082 | 37,366,865 |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $11M | $8M | $5M | $2M | $685.0K | $1M | |
| Stock-based Comp | $34M | $31M | $17M | $8M | $3M | $919.0K | |
| Amort. of Intangibles | $1M | $1M | $500.0K | $0 | · | · | |
| Other Non-cash | $-1M | · | $-8M | $2M | $-735.0K | · | |
| Operating Cash Flow | $-16M | $-37M | $-35M | $-31M | $-17M | $-4M | |
| CapEx | $14M | $12M | $11M | $15M | $3M | $1M | |
| Investing Cash Flow | $13M | $35M | $-81M | $-77M | $-3M | $-1M | |
| Debt Issued | · | · | · | $0 | $0 | $2M | |
| Net Debt Issued | · | · | $0 | $0 | $-2M | · | |
| Financing Cash Flow | $2M | $160.0K | $109M | $21M | $108M | $12M | |
| Net Change in Cash | $-642.0K | $-2M | $-6M | $-86M | $88M | $6M | |
| Free Cash Flow | $-29M | · | $-46M | $-45M | $-20M | · |
Rentabilité 6
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 79.8% | · | 81.2% | 80.6% | 81.1% | · | |
| Operating Margin | -25.5% | · | -27.5% | -24.6% | -17.5% | · | |
| Net Margin | -27.7% | · | -26.5% | -30.2% | -21.8% | · | |
| EBITDA Margin | -20.5% | · | -24.6% | -23.1% | -16.8% | · | |
| ROA | -28.9% | · | -24.1% | -28.6% | -22.5% | · | |
| ROE | -63.8% | · | -35.9% | -69.8% | -21.6% | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | · | 4.4 | 4.4 | 7.6 | · | |
| Quick Ratio | 3.0 | · | 3.6 | 3.7 | 6.8 | · | |
| Debt / Equity | 0.7 | · | 0.4 | 0.9 | 0.3 | · | |
| LT Debt / Equity | 0.6 | · | 0.4 | 0.9 | 0.3 | · | |
| Interest Coverage | -10.2 | · | -10.0 | -7.9 | -4.1 | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | · | 0.9 | 0.9 | 1.0 | · | |
| Inventory Turnover | 1.1 | · | 1.4 | 1.8 | 1.9 | · | |
| Receivables Turnover | 5.1 | · | 5.6 | 5.9 | 5.7 | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 1.6% | 11.9% | 31.9% | 50.2% | 64.6% | · | |
| Revenue CAGR 3Y | 14.5% | 30.4% | 48.3% | · | · | · | |
| Revenue CAGR 5Y | 30.0% | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $213M | $209M | $187M | $142M | $94M | · | |
| Net Income TTM | $-59M | $-56M | $-50M | $-43M | $-21M | · | |
| Market Cap | · | · | $787M | $1.28B | · | · | |
| Enterprise Value | · | · | $717M | $1.25B | · | · | |
| P/E | -2.6 | -8.3 | -15.7 | -29.9 | -43.3 | · | |
| P/S | · | · | 4.2 | 9.0 | · | · | |
| P/B | · | · | 5.7 | 21.1 | · | · | |
| P / Tangible Book | · | · | 6.8 | 21.1 | · | · | |
| P / Cash Flow | · | · | -22.8 | -41.7 | · | · | |
| P / FCF | · | · | -17.1 | -28.1 | · | · | |
| EV / EBITDA | · | · | -15.6 | -38.2 | · | · | |
| EV / FCF | · | · | -15.6 | -27.5 | · | · | |
| EV / Revenue | · | · | 3.8 | 8.8 | · | · | |
| Earnings Yield | -38.0% | -12.1% | -6.3% | -3.4% | -2.3% | · |
Compte de résultat 15
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $47M | $63M | $50M | $47M | $53M | $69M | $45M | $44M | $51M | $62M | $41M | $42M | $42M | $50M | $33M | $30M | |
| Cost of Revenue | $10M | $12M | $11M | $10M | $11M | $13M | $9M | $9M | $10M | $11M | $8M | $8M | $8M | $9M | $6M | $5M | |
| Gross Profit | $37M | $50M | $40M | $38M | $42M | $55M | $36M | $36M | $41M | $51M | $33M | $34M | $34M | $41M | $27M | $25M | |
| R&D Expense | $5M | $5M | $5M | $5M | $6M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | |
| SG&A Expense | $16M | $15M | $16M | $16M | $16M | $14M | $14M | $14M | $14M | $13M | $13M | $10M | $11M | $10M | $9M | $7M | |
| Operating Expenses | $55M | $56M | $55M | $55M | $57M | $56M | $51M | $57M | $60M | $58M | $51M | $47M | $48M | $44M | $38M | $37M | |
| Operating Income | $-17M | $-6M | $-16M | $-17M | $-16M | $-204.0K | $-15M | $-21M | $-19M | $-7M | $-18M | $-13M | $-14M | $-3M | $-11M | $-12M | |
| Interest Expense | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $946.0K | |
| Other Non-op | $-794.0K | $-3M | $-612.0K | $-424.0K | $-340.0K | $-297.0K | $-226.0K | $176.0K | $292.0K | $501.0K | $297.0K | $781.0K | $322.0K | $-915.0K | $-815.0K | $-5M | |
| Net Income | $-18M | $-9M | $-16M | $-17M | $-16M | $-501.0K | $-15M | $-21M | $-19M | $-6M | $-18M | $-12M | $-13M | $-4M | $-12M | $-17M | |
| EPS (Basic) | $-0.28 | $-0.14 | $-0.26 | $-0.28 | $-0.25 | $-0.01 | $-0.25 | $-0.34 | $-0.30 | $-0.10 | $-0.28 | $-0.20 | $-0.23 | $-0.08 | $-0.22 | $-0.31 | |
| EPS (Diluted) | $-0.28 | $-0.14 | $-0.26 | $-0.28 | $-0.25 | $-0.01 | $-0.25 | $-0.34 | $-0.30 | $-0.10 | $-0.28 | $-0.20 | $-0.23 | $-0.08 | $-0.22 | $-0.31 | |
| Shares (Basic) | 64,592,681 | -125,914,707 | 63,515,372 | 63,006,891 | 62,661,447 | -123,991,708 | 62,229,463 | 62,081,494 | 61,792,788 | -120,816,615 | 61,562,494 | 61,382,514 | 58,723,760 | -110,288,315 | 55,429,211 | 55,308,273 | |
| Shares (Diluted) | 64,592,681 | -125,914,707 | 63,515,372 | 63,006,891 | 62,661,447 | -123,991,708 | 62,229,463 | 62,081,494 | 61,792,788 | -120,816,615 | 61,562,494 | 61,382,514 | 58,723,760 | -110,288,315 | 55,429,211 | 55,308,273 | |
| EBITDA | $-16M | · | $-16M | $-17M | $-13M | · | $-15M | $-21M | $-17M | · | $-18M | $-12M | $-13M | · | $-11M | $-12M |
Bilan 30
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $11M | $8M | $8M | $13M | $11M | $12M | $18M | $9M | · | $7M | $12M | $30M | $19M | $89M | $102M | |
| Short-term Investments | $42M | $38M | $50M | $61M | $63M | $64M | $71M | $77M | $101M | · | $115M | $127M | $141M | $62M | · | · | |
| Receivables | $30M | $42M | $33M | $30M | $31M | $41M | $24M | $26M | $30M | $38M | $25M | $27M | $25M | $29M | $19M | $17M | |
| Inventory | $36M | $36M | $41M | $42M | $38M | $39M | $44M | $41M | $36M | · | $29M | $26M | $23M | $19M | $17M | $13M | |
| Prepaid Expense | $5M | $6M | $6M | $6M | $4M | $6M | $7M | $10M | $11M | · | $11M | $5M | $5M | $4M | $4M | $4M | |
| Current Assets | $123M | $132M | $138M | $148M | $149M | $161M | $158M | $172M | $187M | · | $187M | $198M | $223M | $133M | $128M | $135M | |
| PP&E (Net) | $32M | $30M | $30M | $30M | $27M | $26M | $25M | $24M | $25M | · | $22M | $19M | $16M | $15M | $14M | $9M | |
| PP&E (Gross) | $56M | $54M | $52M | $49M | $45M | $41M | $39M | $37M | $35M | · | $29M | $25M | $21M | $20M | $18M | $12M | |
| Accum. Depreciation | $24M | $24M | $22M | $20M | $18M | $15M | $14M | $12M | $10M | · | $7M | $6M | $5M | $4M | $4M | $3M | |
| Goodwill | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | · | $13M | $13M | · | $0 | · | · | |
| Intangibles | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $9M | · | $9M | $10M | · | $0 | · | · | |
| Other Non-current Assets | $1M | $1M | $614.0K | $676.0K | $387.0K | $407.0K | $458.0K | $146.0K | $146.0K | · | $146.0K | $146.0K | $215.0K | $146.0K | $146.0K | $134.0K | |
| Total Assets | $184M | $191M | $197M | $206M | $206M | $217M | $213M | $226M | $243M | · | $240M | $250M | $249M | $159M | $156M | $159M | |
| Accounts Payable | $14M | $7M | $16M | $20M | $13M | $11M | $19M | $18M | $21M | · | $9M | $8M | $5M | $9M | $8M | $3M | |
| Accrued Liabilities | $6M | $6M | $7M | $6M | $6M | $7M | $8M | $14M | $15M | · | $9M | $7M | $8M | $6M | $5M | $5M | |
| Short-term Debt | $2M | $2M | $2M | $1M | $45.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $34M | $31M | $41M | $42M | $33M | $35M | $38M | $44M | $47M | · | $33M | $30M | $23M | $30M | $23M | $17M | |
| Capital Leases | $14M | $14M | $13M | $13M | $14M | $16M | $16M | $16M | $16M | · | $16M | $17M | $15M | $16M | $19M | $18M | |
| Other Non-current Liabilities | $3M | $3M | $37.0K | $37.0K | $37.0K | $37.0K | $37.0K | $37.0K | $37.0K | · | $37.0K | $37.0K | $25.0K | $0 | · | · | |
| Total Liabilities | $107M | $103M | $107M | $109M | $101M | $104M | $108M | $114M | $116M | · | $102M | $100M | $92M | $98M | $94M | $87M | |
| Long-term Debt | $56M | $56M | $54M | $53M | $53M | $53M | $53M | $53M | $53M | · | $53M | $53M | $53M | $53M | $53M | $53M | |
| Total Debt | $58M | · | $55M | $55M | $53M | · | $53M | $53M | $53M | · | $53M | $53M | $53M | · | $53M | $53M | |
| Common Stock | $65.0K | $64.0K | $64.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $62.0K | · | $62.0K | $62.0K | $61.0K | $55.0K | $46.0K | $46.0K | |
| Paid-in Capital | $345M | $337M | $330M | $322M | $312M | $303M | $294M | $286M | $279M | · | $266M | $261M | $256M | $145M | $142M | $140M | |
| Retained Earnings | $-267M | $-249M | $-240M | $-223M | $-206M | $-190M | $-189M | $-174M | $-153M | · | $-128M | $-110M | $-98M | $-85M | $-80M | $-68M | |
| Treasury Stock | $1M | $1M | $1M | $696.0K | $682.0K | $281.0K | $250.0K | $250.0K | $250.0K | · | · | · | · | $0 | · | · | |
| AOCI | $-26.0K | $72.0K | $83.0K | $50.0K | $57.0K | $97.0K | $191.0K | $-26.0K | $69.0K | · | $-148.0K | $-219.0K | $-56.0K | $-27.0K | · | · | |
| Stockholders' Equity | $77M | $87M | $89M | $98M | $105M | $113M | $105M | $112M | $126M | $138M | $138M | $150M | $158M | $61M | $62M | $72M | |
| Liabilities + Equity | $184M | $191M | $197M | $206M | $206M | $217M | $213M | $226M | $243M | · | $240M | $250M | $249M | $159M | $156M | $159M | |
| Shares Outstanding | · | · | · | · | · | · | 62,275,371 | 62,175,241 | 61,929,172 | · | 61,606,926 | 61,528,409 | 61,280,703 | 55,628,208 | 55,499,242 | 55,391,309 |
Flux de trésorerie 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $899.0K | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $924.0K | $999.0K | $400.0K | $400.0K | |
| Stock-based Comp | $8M | $8M | $8M | $10M | $9M | $9M | $8M | $7M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | $2M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | $300.0K | $200.0K | · | · | $0 | $0 | · | |
| Other Non-cash | $16M | · | · | · | $9M | · | · | · | $2M | · | · | · | $-7M | · | · | · | |
| Operating Cash Flow | $7M | $-8M | $-9M | $-3M | $4M | $-4M | $-12M | $-14M | $-7M | $532.0K | $-10M | $-8M | $-17M | $-5M | $-7M | $-11M | |
| CapEx | $3M | $2M | $3M | $5M | $4M | $3M | $3M | $2M | $4M | $2M | $4M | $4M | $1M | $2M | $6M | $5M | |
| Investing Cash Flow | $-8M | $10M | $9M | $-3M | $-2M | $3M | $6M | $22M | $4M | $5M | $5M | $-10M | $-80M | $-64M | $-6M | $-5M | |
| Financing Cash Flow | $-588.0K | $1M | $-10.0K | $987.0K | $-282.0K | $26.0K | $8.0K | $311.0K | $-185.0K | $165.0K | $159.0K | $1M | $108M | $297.0K | $353.0K | $19M | |
| Net Change in Cash | $-1M | $3M | $-366.0K | $-5M | $2M | $-760.0K | $-6M | $9M | $-4M | $6M | $-5M | $-18M | $10M | $-69M | $-13M | $3M | |
| Free Cash Flow | $4M | · | · | · | $655.0K | · | · | · | $-11M | · | · | · | $-19M | · | · | · |
Rentabilité 6
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.3% | · | 79.1% | 79.7% | 79.7% | · | 80.1% | 80.2% | 80.2% | · | 80.4% | 81.7% | 81.0% | · | 80.0% | 81.1% | |
| Operating Margin | -36.4% | · | -31.2% | -35.8% | -29.6% | · | -33.6% | -48.1% | -37.1% | · | -43.7% | -31.1% | -32.6% | · | -34.2% | -39.8% | |
| Net Margin | -38.0% | · | -32.4% | -36.7% | -30.3% | · | -34.1% | -47.7% | -36.5% | · | -43.0% | -29.2% | -31.9% | · | -36.7% | -57.5% | |
| EBITDA Margin | -34.5% | · | -31.2% | -35.8% | -25.0% | · | -33.6% | -48.1% | -33.4% | · | -43.7% | -28.5% | -30.5% | · | -33.0% | -38.5% | |
| ROA | -9.2% | · | -8.0% | -8.0% | -7.1% | · | -6.8% | -8.9% | -7.6% | · | -8.8% | -6.0% | -6.8% | · | -8.2% | -11.5% | |
| ROE | -19.7% | · | -16.8% | -16.6% | -13.7% | · | -12.7% | -16.2% | -13.2% | · | -17.5% | -11.1% | -11.0% | · | -15.2% | -19.7% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | · | 3.4 | 3.5 | 4.5 | · | 4.1 | 3.9 | 4.0 | · | 5.6 | 6.6 | 9.6 | · | 5.7 | 8.1 | |
| Quick Ratio | 2.4 | · | 2.2 | 2.4 | 3.2 | · | 2.8 | 2.7 | 3.0 | · | 4.4 | 5.6 | 8.4 | · | 4.7 | 7.1 | |
| Debt / Equity | 0.7 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.8 | 0.7 | |
| LT Debt / Equity | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.8 | 0.7 | |
| Interest Coverage | -10.9 | · | -11.7 | -12.8 | -11.9 | · | -11.5 | -16.3 | -14.4 | · | -13.7 | -10.2 | -10.7 | · | -9.5 | -12.6 |
Efficacité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.3 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.5 | · | 1.8 | 1.7 | 1.7 | · | 1.8 | 1.7 | 1.8 | · | 1.9 | 1.9 | 2.0 | · | 2.2 | 2.3 |
Valorisation (TTM) 14
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $197M | · | $195M | $189M | $193M | · | $181M | $178M | $176M | · | $158M | $147M | $134M | · | $114M | $101M | |
| Net Income TTM | $-68M | · | $-65M | $-70M | $-71M | · | $-73M | $-70M | $-62M | · | $-55M | $-55M | $-52M | · | $-45M | $-38M | |
| Market Cap | · | · | · | · | · | · | $361M | $413M | $808M | · | $808M | $1.57B | $1.54B | · | $1.22B | $794M | |
| Enterprise Value | · | · | · | · | · | · | $332M | $372M | $751M | · | $738M | $1.49B | $1.43B | · | $1.19B | $745M | |
| P/E | -1.3 | · | -6.5 | -5.2 | -7.4 | · | -5.0 | -5.9 | -12.9 | · | -14.1 | -26.6 | -27.4 | · | -27.2 | -20.8 | |
| P/S | · | · | · | · | · | · | 2.0 | 2.3 | 4.6 | · | 5.1 | 10.7 | 11.5 | · | 10.8 | 7.8 | |
| P/B | · | · | · | · | · | · | 3.4 | 3.7 | 6.4 | · | 5.9 | 10.5 | 9.8 | · | 19.7 | 11.1 | |
| P / Tangible Book | · | · | · | · | · | · | 4.3 | 4.6 | 7.7 | · | 7.0 | 12.3 | 9.8 | · | 19.7 | 11.1 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | -111.9 | · | · | · | -89.4 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | -72.5 | · | · | · | -82.4 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | -21.9 | -17.4 | -44.0 | · | -41.4 | -124.4 | -110.9 | · | -108.9 | -64.6 | |
| EV / FCF | · | · | · | · | · | · | · | · | -67.4 | · | · | · | -76.1 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 1.8 | 2.1 | 4.3 | · | 4.7 | 10.1 | 10.6 | · | 10.5 | 7.4 | |
| Earnings Yield | -79.8% | · | -15.5% | -19.1% | -13.6% | · | -20.2% | -16.8% | -7.7% | · | -7.1% | -3.8% | -3.6% | · | -3.7% | -4.8% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $213M | $209M | $187M | $142M | $94M |
| Marge Brute % | 79.8% | — | 81.2% | 80.6% | 81.1% |
| Marge d'exploitation % | -25.5% | — | -27.5% | -24.6% | -17.5% |
| Résultat net | $-59M | $-56M | $-50M | $-43M | $-21M |
| BPA dilué | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.43 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.7 | — | 0.4 | 0.9 | 0.3 |
| Ratio de liquidité | 4.3 | — | 4.4 | 4.4 | 7.6 |
| Ratio de liquidité réduite | 3.0 | — | 3.6 | 3.7 | 6.8 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-29M | — | $-46M | $-45M | $-20M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.